Finance

Lists
APLLTD:NSE
Alembic Pharmaceuticals Ltd
₹1,029.50
+1.20%
(+12.20) 1D
Nov 11, 3:30:03 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
₹1,023.00
High
₹1,051.50
Low
₹1,021.15
Mkt. cap
202.29B
Avg. vol.
449.05K
Volume
540.26K
Dividend
1.17%
Quarterly dividend
₹3.00
Ex-dividend date
Jul 29, 2026
P/E ratio
23.99
52-wk high
₹1,055.70
52-wk low
₹635.80
EPS
₹42.92
Shares outstanding
188.50M
No. of employees
17K
Open
₹1,023.00
High
₹1,051.50
Low
₹1,021.15
Mkt. cap
202.29B
Avg. vol.
449.05K
Volume
540.26K
Dividend
1.17%
Quarterly dividend
₹3.00
Ex-dividend date
Jul 29, 2026
P/E ratio
23.99
52-wk high
₹1,055.70
52-wk low
₹635.80
EPS
₹42.92
Shares outstanding
188.50M
No. of employees
17K
News stories
From web sources and news partners
About Alembic Pharmaceuticals Ltd
CEO-
Employees17.2K
Founded1907
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Website-
Last report
Nov 4, 2026
Fiscal period
Q2 2027
₹39.31 / ₹10.97
+258.45%beat
Revenue / Est. (INR)
26.03B / 23.34B
+11.57%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
18.76B
18.48B
21.50B
26.03B
Cost of goods sold
5.29B
6.27B
6.20B
6.86B
Cost of revenue
5.29B
6.27B
6.20B
6.86B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.33B
4.39B
4.74B
5.04B
Operating expense
11.34B
10.85B
12.96B
14.55B
Total operating expenses
16.63B
17.11B
19.16B
21.41B
Operating income
2.13B
1.36B
2.34B
4.62B
Other non operating income
154.90M
-285.60M
149.30M
151.20M
EBT including unusual items
1.61B
1.19B
2.22B
4.38B
EBT excluding unusual items
2.04B
1.37B
2.22B
4.38B
Income tax expense
295.40M
-829.00M
495.00M
1.04B
Effective tax rate
18.29%
-69.88%
22.31%
23.76%
Other operating expenses
6.21B
5.56B
7.24B
8.51B
Net income
1.33B
2.03B
1.73B
3.35B
Net profit margin
7.09%
10.97%
8.05%
12.87%
Earnings per share
8.51
11.57
8.80
39.31
Interest and investment income
-
8.60M
-
-
Interest expense
-233.10M
-225.60M
-276.10M
-382.60M
Net interest expenses
-233.10M
-217.00M
-276.10M
-382.60M
Depreciation and amortization charges
801.20M
885.90M
977.10M
1.01B
EBITDA
2.78B
2.12B
3.09B
5.62B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps